middle.news
AdAlta Advances CAR-T Therapy with East-to-West Strategy and Australian Manufacturing Transfer
8:26pm on Friday 15th of May, 2026 AEST
•
Healthcare
Read Story
AdAlta Advances CAR-T Therapy with East-to-West Strategy and Australian Manufacturing Transfer
8:26pm on Friday 15th of May, 2026 AEST
Key Points
Co-development of BZDS1901 CAR-T therapy with Shanghai Cell Therapy Group
Complete tumour clearance achieved in advanced mesothelioma patients
Manufacturing transfer to Australia with automation partnership
Raised $1.2 million via private placement
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
AdAlta (ASX:1AD)
OPEN ARTICLE